Kolkata, June 20 (FN Agency) Meril, a global medical device company based in India, has launched its cutting-edge surgical robotic technology, MISSO, on Thursday. This indigenously developed robotic system is designed to provide surgeons with real-time assistance during knee replacement procedures, ensuring clinical accuracy. This indigenously developed technology promises to reduce costs by around 66 percent, making knee surgeries more accessible. Manish Deshmukh, Head of Marketing for India and Global at Meril, stated, “Meril is pleased to bring MISSO, which has the potential to democratise robotic knee replacement surgery in India.”
He highlighted the surge in osteoarthritis cases from 23 million to 62 million over the last 20-25 years and emphasized that the widespread use of robotic surgery could better address the gap between the need and adoption of knee replacement surgeries. MISSO has received approval from the Central Drugs Standard Control Organisation (CDSCO) and is awaiting CE and USFDA approvals. The robot boasts a success rate of about 98 percent and helps less experienced surgeons achieve high precision. Dr. Santosh Kumar, Chief Joint Replacement Surgeon at Belle Vue Clinic, remarked, “With MISSO, there is an opportunity to expand access to robotic surgery in India and provide relief to a larger number of patients affected by chronic knee pain.”
MISSO’s compact design makes it suitable for smaller hospitals, and its AI integration reduces pre-operative planning time by 83 percent. This system promises better surgical outcomes, reduced complications, and quicker patient recovery. In India, around 30 percent of people over 40 suffer from knee osteoarthritis. Out of the 32 lakh patients needing knee replacement annually, only 5.5 lakhs currently undergo the surgery. Robotic surgery, such as that offered by MISSO, reduces recovery time, pain, and complications compared to traditional methods, bringing advanced knee surgery to Tier 2 and Tier 3 cities.